Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
- PMID: 16279145
- DOI: 10.1191/1740774505cn085oa
Randomized controlled trials of aprotinin in cardiac surgery: could clinical equipoise have stopped the bleeding?
Abstract
Background: Aprotinin is a serine protease inhibitor used to limit perioperative bleeding and reduce the need for donated blood transfusions during cardiac surgery. Randomized controlled trials of aprotinin evaluating its effect on the outcome of perioperative transfusion have been published since 1987, and systematic reviews were conducted in 1992 and 1997.
Methods: A systematic search was conducted for all RCTs of aprotinin that used placebo controls or were open-label with no active control treatment. Data collected included the primary outcome, objective of each study, whether a systematic review was cited or conducted as part of the background and/or rationale for the study and the number of previously published RCTs cited. Cumulative meta-analyses were performed.
Results: Sixty-four randomized, controlled trials of aprotinin were found, conducted between 1987 and 2002, reporting an endpoint of perioperative transfusion. Median trial size was 64 subjects, with a range of 20 to 1784. A cumulative meta-analysis indicated that aprotinin greatly decreased the need for perioperative transfusion, stabilizing at an odds ratio of 0.25 (p < 10 - 6) by the 12th study, published in June of 1992. The upper limit of the confidence interval never exceeded 0.65 and results were similar in all subgroups. Citation of previous RCTs was extremely low, with a median of 20% of prior trials cited. Only 7 of 44 (15%) of subsequent reports referenced the largest trial (N = 1784), which was 28 times larger than the median trial size.
Conclusions: This study demonstrates that investigators evaluating aprotinin were not adequately citing previous research, resulting in a large number of RCTs being conducted to address efficacy questions that prior trials had already definitively answered. Institutional review boards and journals could reduce the number of redundant trials by requiring investigators to conduct adequate searches for prior evidence and conducting systematic reviews.
Similar articles
-
Drugs to minimize perioperative blood loss in cardiac surgery: meta-analyses using perioperative blood transfusion as the outcome. The International Study of Peri-operative Transfusion (ISPOT) Investigators.Anesth Analg. 1997 Dec;85(6):1258-67. doi: 10.1097/00000539-199712000-00014. Anesth Analg. 1997. PMID: 9390590
-
Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints.Lancet. 1999 Dec 4;354(9194):1940-7. doi: 10.1016/S0140-6736(99)01264-7. Lancet. 1999. PMID: 10622296
-
Bleeding in cardiac surgery: the use of aprotinin does not affect survival.J Thorac Cardiovasc Surg. 2008 Mar;135(3):495-502. doi: 10.1016/j.jtcvs.2007.11.045. J Thorac Cardiovasc Surg. 2008. PMID: 18329459
-
Aprotinin: 1 year on.Curr Opin Anaesthesiol. 2009 Feb;22(1):121-7. doi: 10.1097/ACO.0b013e32831c833f. Curr Opin Anaesthesiol. 2009. PMID: 19295302 Review.
-
Use of aprotinin to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis.Transfus Apher Sci. 2014 Oct;51(2):152-61. doi: 10.1016/j.transci.2014.07.009. Epub 2014 Aug 1. Transfus Apher Sci. 2014. PMID: 25129829 Review.
Cited by
-
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.BMJ. 2010 Mar 23;340:c869. doi: 10.1136/bmj.c869. BMJ. 2010. PMID: 20332511 Free PMC article. No abstract available.
-
The proportion of randomized controlled trials that inform clinical practice.Elife. 2022 Aug 17;11:e79491. doi: 10.7554/eLife.79491. Elife. 2022. PMID: 35975784 Free PMC article.
-
Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period.Blood Transfus. 2011 Jan;9(1):19-40. doi: 10.2450/2010.0074-10. Blood Transfus. 2011. PMID: 21235852 Free PMC article. No abstract available.
-
Selective citation in scientific literature on the human health effects of bisphenol A.Res Integr Peer Rev. 2019 Mar 29;4:6. doi: 10.1186/s41073-019-0065-7. eCollection 2019. Res Integr Peer Rev. 2019. PMID: 30976459 Free PMC article.
-
Network meta-analyses: Methodological prerequisites and clinical usefulness.World J Methodol. 2022 May 20;12(3):92-98. doi: 10.5662/wjm.v12.i3.92. eCollection 2022 May 20. World J Methodol. 2022. PMID: 35721244 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical